Evidence map›Paper›PMID 35743788›Full record

ArticleJournal of personalized medicine2022

Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.

Vojtěch Viktorin, Inga Griškova-Bulanova, Aleksandras Voicikas, Dominika Dojčánová, Peter Zach, Anna Bravermanová, Veronika Andrashko, Filip Tylš, Jakub Korčák, Michaela Viktorinová and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Psilocybin's effects on cognition and creativity: A scoping review.Journal of psychopharmacology (Oxford, England) · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Vojtěch ViktorinNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.ORCID 0000-0003-0801-2244
Inga Griškova-BulanovaNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.ORCID 0000-0001-5003-3300
Aleksandras VoicikasInstitute of Biosciences, Vilnius University, 7 Saulėtekio Ave, 10257 Vilnius, Lithuania.
Dominika DojčánováNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Peter ZachNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Anna BravermanováNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Veronika AndrashkoNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Filip TylšNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Jakub KorčákNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Michaela ViktorinováNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Vlastimil KoudelkaNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.ORCID 0000-0002-7553-7529
Kateřina HájkováForensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.
Martin KuchařForensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague, Czech Republic.ORCID 0000-0002-7616-6352
Jiří HoráčekNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Martin BrunovskýNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Tomáš PáleníčekNational Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.
Charles University · CZNational Institute of Mental Health · CZUniversity of Chemistry and Technology, Prague · CZVilnius University · LT

Funding

Czech Health Research Council NU21-04-00307; NV18-04-00260Czech Science Foundation 20-25349S; 21-32608SLong-term conceptual development of research organization RVO 00023752Specific University Research, Czech Ministry of Education, Youth and Sports 260533/SVV/2021
6 · The paper itself

Abstract

Psilocybin is a classical serotoninergic psychedelic that induces cognitive disruptions similar to psychosis. Gamma activity is affected in psychosis and is tightly related to cognitive processing. The 40 Hz auditory steady-state responses (ASSR) are frequently used as indicators to test the ability to generate gamma activity. Based on previous literature, we studied the impact of psilocybin on 40 Hz ASSR in healthy volunteers. The study was double blind and placebo controlled with a crossover design. A sample of 20 healthy subjects (10M/10F) received psilocybin orally 0.26 mg/kg or placebo. Participants were measured four times in total, one time before ingestion of psilocybin/placebo and one time after ingestion, during the peak of intoxication. A series of 500 ms click trains were used for stimulation. Psilocybin induced a psychedelic effect and decreased 40 Hz ASSR phase-locking index compared to placebo. The extent of the attenuation was related to Cognition and Affect on the Hallucinogen Rating Scale. The current study shows that psilocybin lowers the synchronization level and the amplitude of 40 Hz auditory steady-state responses, which yields further support for the role of gamma oscillations in cognitive processing and its disturbance.

Indexed as

auditory steady-state responseEEGmodel of psychosispsilocybinpsychedelicsserotonin

Identifiers

PMID35743788
PMCPMC9225116
OpenAlexW4283160987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.